Endothelial dysfunction predicted increased left atrial volume index in newly diagnosed nondiabetic hypertensive

Mustafa Çetin1, Turan Erdoğan1, Tuncay Kiriş2

  • 1Department of Cardiology, Recep Tayyip Erdogan Research and Training Hospital, Rize.

Blood Pressure Monitoring
|November 26, 2019
PubMed

Insights

Endothelial dysfunction, indicated by reduced flow-mediated dilation (FMD%), predicts left atrial volume increase in new hypertension patients. This highlights FMD% as a key predictor for cardiovascular risk in hypertension.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Hypertension Research

Background:

  • Arterial hypertension is a major risk factor for cardiovascular morbidity and mortality.
  • Left atrial volume increase is linked to adverse cardiovascular outcomes, including mortality and atherosclerotic heart disease.
  • Predicting left atrial volume changes is crucial for managing hypertension-related cardiovascular risk.

Purpose of the Study:

  • To investigate the predictive value of endothelial dysfunction for left atrial volume increase.
  • To assess the relationship between brachial artery flow-mediated dilation (FMD%) and left atrial volume in newly diagnosed hypertension.

Main Methods:

  • Study included 96 newly diagnosed hypertensive patients.
  • Measurements included left atrium volume, left ventricular ejection fraction, pulse wave velocity, and brachial artery flow-mediated dilation (FMD%).

Main Results:

  • Patients with higher left atrial volume index showed significantly increased left ventricle mass index, septal and posterior wall thickness, and end-diastolic diameter.
  • Flow-mediated dilation (FMD%) was significantly lower in patients with higher left atrial volume index (9.7 ± 3.5% vs. 13.31 ± 6.01%).
  • Higher left atrial volume index was associated with lower lateral wall E wave velocity, longer isovolumetric relaxation time, and higher E/E' ratio.

Conclusions:

  • Isovolumetric relaxation time, flow-mediated dilation (FMD%), and the E/E' ratio independently predict left atrial volume index increase in newly diagnosed hypertension.
  • Endothelial dysfunction, assessed by FMD%, is a valuable predictor of left atrial remodeling in early hypertension.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
633
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
418
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
690
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
329
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.7K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
325